Sun | Jun 16, 2019

IAAF ordered by court to suspend Semenya testosterone rules

Published:Monday | June 3, 2019 | 4:04 PM
In this April 13, 2018, file photo, South Africa's Caster Semenya celebrates after winning the woman's 800m final at Carrara Stadium during the 2018 Commonwealth Games on the Gold Coast, Australia. (AP Photo/Mark Schiefelbein, File)

LAUSANNE, Switzerland (AP) — Caster Semenya won an interim ruling in her battle against the IAAF and its testosterone regulations when the Swiss supreme court ordered athletics’ governing body to suspend the rules on Monday.

The freezing of the rules allows the two-time Olympic champion from South Africa to run in her favorite 800-meter event without taking any hormone suppressing medication, although the temporary ruling can be challenged by the IAAF.

Semenya’s lawyers said there will be another decision by the supreme court after the IAAF makes its arguments to the court that the rules should stand.

No date was given for that hearing but it could happen as early as this month, Semenya’s South Africa-based lawyer, Greg Nott, said.

The temporary suspension of the rules comes after the 28-year-old Semenya last week filed an appeal to the Swiss supreme court asking for the testosterone limits in female events to be removed completely.

The full appeal against a decision by the Court of Arbitration for Sport could take up to a year or more to be heard by the supreme court, which is also known as the Swiss Federal Tribunal.

That full appeal will be heard by a panel of Swiss federal judges.

“I am thankful to the Swiss judges for this decision,” Semenya said in a statement. “I hope that following my appeal I will once again be able to run free.”

If the testosterone rules stay suspended, Semenya would likely be cleared to run in the 800 for the remainder of the Diamond League and, crucially, be able to defend her title at the world championships in Doha, Qatar, in September.

We want to hear from you! Send us a message on WhatsApp at 1-876-499-0169, email us at editors@gleanerjm.com or onlinefeedback@gleanerjm.com.